Literature DB >> 15748466

Management of excessive tearing as a side effect of docetaxel.

Bita Esmaeli1.   

Abstract

Docetaxel is a highly effective chemotherapeutic agent for metastatic or locally advanced breast cancer as well as other malignancies. One of the side effects of weekly administration of docetaxel is epiphora (excessive tearing) caused by canalicular stenosis and nasolacrimal duct obstruction. This article summarizes experience with epiphora and canalicular stenosis as a side effect of docetaxel and provides specific recommendations for management of this side effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15748466     DOI: 10.3816/cbc.2005.n.004

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  3 in total

Review 1.  Breast cancer medications and vision: effects of treatments for early-stage disease.

Authors:  Alvin Eisner; Shiuh-Wen Luoh
Journal:  Curr Eye Res       Date:  2011-08-05       Impact factor: 2.424

2.  Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report.

Authors:  Thomas P Moloney; Wen Xu; Kristopher Rallah-Baker; Niara Oliveira; Natasha Woodward; Jonathon J Farrah
Journal:  BMC Ophthalmol       Date:  2014-02-24       Impact factor: 2.209

3.  Docetaxel for the post-surgery treatment of patients with node-positive breast cancer.

Authors:  Shubham Pant; Meena P Chilukuri; Bhuvaneswari Ramaswamy
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.